ArticleInfection and drug resistance2019
Serological evidence of
Article in Infection and drug resistance, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
25 citing papers in PubMed, 34 citations in OpenAlex.
- High Seropositivity toAnimals : an open access journal from MDPI · 2026Article
- Relationship of the Landscape Configuration with the Gut Parasites and Fungi Diversity in Farm Animals Associated with Conservation Areas in Colombia: Epidemiological Risk to Wildlife.Acta parasitologica · 2025Article
- A first insight into the occurrence ofOne health (Amsterdam, Netherlands) · 2025Article
- Guinea pigs raised as livestock are incidental host ofFrontiers in veterinary science · 2025Article
- Unveiling Q fever in Latin America: beyond occupational risks to vulnerable populations and environmental transmission.Frontiers in public health · 2025Article
- A first insight into seropositivity and risk factors forOne health (Amsterdam, Netherlands) · 2024Article
- Herd-level seroprevalence, molecular prevalence, and trends ofVeterinary world · 2024Article
- Shedding light on risk: Seroprevalence of Q fever among farm animals and workers in Ecuador.One health (Amsterdam, Netherlands) · 2024Article
- Article
- Serosurvey ofMicroorganisms · 2024Article
- Is there a higher risk of exposure toOne health (Amsterdam, Netherlands) · 2023Article
- Leptospirosis in Ecuador: Current Status and Future Prospects.Tropical medicine and infectious disease · 2023Review
- Transmission dynamics of Q fever in French Guiana: A population-based cross-sectional study.Lancet regional health. Americas · 2022Article
- First Description of Acaricide Resistance in Populations ofAnimals : an open access journal from MDPI · 2022Article
- Seroprevalence and Risks Factors Associated withEpidemiologia (Basel, Switzerland) · 2022Article
- Immunogenicity and Reactogenicity in Q Fever Vaccine Development.Frontiers in immunology · 2022Review
- Coxiella burnetii abortion in a dairy farm selling artisanal cheese directly to consumers and review of Q fever as a bovine abortifacient in South America and a human milk-borne disease.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2021Review
- The first report of seroprevalence of Q fever in water buffaloes (Veterinary world · 2021Article
- National Seroprevalence ofPathogens (Basel, Switzerland) · 2021Article
- Subunit Vaccines Using TLR Triagonist Combination Adjuvants Provide Protection AgainstFrontiers in immunology · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors at 5 institutions in 4 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.